Skip to main content
. Author manuscript; available in PMC: 2019 Jul 9.
Published in final edited form as: Lancet Diabetes Endocrinol. 2018 Feb 27;6(5):392–403. doi: 10.1016/S2213-8587(18)30027-5

Table 5.

Trends in diabetic renal disease markers in U.S. adults aged ≥ 18 years by glycemic status, NHANES 1988 to 2014

1988–1994 1999–2004 2005–2010 2011–2014 Δ from 88–94 to
11–14
P interaction
n=8007 n=6640 n=7861 n=5463 P trend
Any CKD 0.038
Diagnosed diabetes 30.3 (26.2–34.7) 31.8 (29.0–34.7) 29.6 (27.1–32.1) 29.6 (26.2–33.3) −0.7 (−6.0, 4.6) 0.612
Undiagnosed diabetes 22.1 (18.1–26.7) 31.1 (23.9–39.2) 19.9 (15.9–24.7) 20.4 (13.8–29.2) −1.7 (−10.3, 6.9) 0.283
Prediabetes 12.4 (10.6–14.4) 13.1 (11.4–15.1) 12.4 (10.9–14.2) 11.4 (9.9–13.1) −1.0 (−3.4, 1.4) 0.353
Normal glycemic status 7.0 (5.9–8.2) 9.4 (8.4–10.6) 9.2 (7.9–10.7) 10.4 (8.7–12.4) +3.4 (1.2, 5.6) 0.002
ACR≥=30 0.001
Diagnosed diabetes 29.9 (26.3–33.8) 27.1 (24.4–30.0) 24.5 (22.3–26.8) 23.8 (20.7–27.3) −6.1 (−10.8, −1.4) 0.005
Undiagnosed diabetes 16.5 (13.0–20.6) 25.3 (18.5–33.6) 16.7 (13.3–20.7) 17.5 (11.3–25.9) 1.0 (−7.0, 9.0) 0.729
Prediabetes 9.3 (7.7–11.2) 9.1 (7.8–10.6) 8.9 (7.7–10.3) 7.7 (6.8–8.8) −1.6 (−3.6, 0.4) 0.118
Normal glycemic status 5.2 (4.4–6.2) 6.2 (5.3–7.3) 6.4 (5.3–7.6) 7.5 (6.1–9.3) +2.3 (0.5, 4.1) 0.010
Median ACR **
Diagnosed diabetes 22.0 (16.4–27.6) 18.9 (14.2–23.6) 19.6 (15.2–24.1) 18.5 (15.8–21.2) −3.5 (−6.3, −0.6) 0.015
Undiagnosed diabetes 14.0 (6.1–20.0) 18.1 (10.2–27.1) 16.8 (9.0–22.7) 16.6 (11.8–19.9) 2.6 (−0.1, 5.7) **
Prediabetes 10.4 (9.3–11.4) 10.6 (9.5–11.6) 10.6 (9.6–11.6) 11.0 (10.4–11.7) 0.7 (0.3, 1.1) 0.004
Normal glycemic status 10.0 (9.0–11.0) 9.7 (8.7–10.7) 10.0 (9.1–11.0) 10.7 (10.0–11.4) 0.7 (0.4, 0.9) <0.001
eGFR<60 0.002
Diagnosed diabetes 7.7 (5.9–9.9) 9.5 (8.2–10.9) 10.2 (8.9–11.6) 11.8 (10.4–13.3) +4.1 (1.7, 6.5) 0.002
Undiagnosed diabetes 7.1 (5.1–9.9) 8.0 (5.8–10.8) 6.2 (4.7–8.1) 6.8 (4.3–10.4) −0.4 (−4.1, 3.3) 0.622
Prediabetes 4.7 (3.9–5.5) 5.7 (4.7–6.9) 5.0 (4.3–5.9) 4.6 (3.7–5.9) 0.0 (−1.4, 1.4) 0.769
Normal glycemic status 2.2 (1.8–2.8) 5.1 (4.2–6.2) 4.3 (3.4–5.3) 3.8 (2.8–5.0) +1.5 (0.3, 2.7) 0.013
Mean eGFR <0.001
Diagnosed diabetes 96.1 (93.7–98.4) 92 (90.6–93.3) 92.0 (90.5–93.5) 90.4 (88.4–92.5) −5.7 (−8.8, −2.6) 0.001
Undiagnosed diabetes 97.0 (94.0–100.0) 98.1 (94.6–101.5) 96.0 (93.3–98.7) 102 (96.9–107.2) 5.0 (−0.9, 10.9) 0.162
Prediabetes 96.1 (94.5–97.7) 91.4 (90.1–92.7) 94.4 (93.5–95.4) 94.0 (92.4–95.6) −2.1 (−4.3, 0.1) 0.335
Normal glycemic status 99.4 (97.9–100.9) 92.3 (91.2–93.3) 94.8 (93.8–95.8) 94.7 (93.3–96.1) −4.7 (−6.8, −2.6) <0.001
Hyperfiltration 0.269
Diagnosed diabetes 13.6 (8.9–20.3) 5.8 (4.4–7.7) 7.6 (5.9–9.8) 7.2 (5.3–9.7) −6.4 (−12.5, −0.3) 0.042
Undiagnosed diabetes 7.3 (3.5–14.4) 14.5 (8.9–22.8) 8.2 (5.4–12.3) 12.0 (6.5–21.1) 4.7 (−4.0, 13.4) 0.523
Prediabetes 5.2 (3.9–6.9) 3.3 (2.4–4.4) 3.8 (3.0–4.8) 4.3 (3.2–5.7) −0.9 (−2.9, 1.1) 0.500
Normal glycemic status 6.1 (4.9–7.5) 3.8 (3.2–4.6) 4.5 (3.8–5.2) 4.4 (3.7–5.3) −1.7 (−3.1, −0.3) 0.068

NHANES, National Health and Nutrition Examinations Surveys; yr, year; FPG, fasting plasma glucose; ACR, albumin-creatinine ratio; eGFR, estimated glomerular filtration rate

Any CKD refers to either of: urine ACR>=30 and/or eGFR<60

Hyperfiltration defined as GFR>=135 ml/min/1.73m2

All analyses adjusted for age, sex, and race/ethnicity

P for trend: Calculated for each glycemic status group by including a continuous variable for the midpoint of each survey period in logistic regression models; significant values indicated variation over time within glycemic groups

P for interaction: significant P-values indicated varying associations between prevalence estimates over time across glycemic groups

**

Relative standard error >30% indicates that estimate may be unreliable